|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online November 9, 2000 as doi:10.1096/fj.00-0336fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,2



,2
,23
* Departments of Medicine and
The Sam and Rose Stein Institute for Research on Aging, University of California San Diego, La Jolla, California 92093-0663, USA;
San Diego Health Care System and Veterans Medical Research Foundation, San Diego, California 92161, USA; and
§ Centre National de la Recherche Scientifique, UMR1599, Institut Gustave Roussy, F-94805 Villejuif, France
3Correspondence: Department of Medicine-0663, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0663, USA. E-mail: lleoni{at}ucsd.edu
SPECIFIC AIMS
HIV-1 induces apoptosis and leads to CD4+ T lymphocyte depletion in humans. It is still unclear whether HIV-1 kills infected cells directly or indirectly. In this study we provide a mechanistic view on how HIV-1 induces apoptotic death of infected primary human CD4+ T lymphocytes.
PRINCIPAL FINDINGS
1. HIV damages mitochondria, leading to cytochrome c
release and caspase activation
The time course of activation of the extrinsic and intrinsic
pathways of apoptosis was examined after HIV-1 infection of primary
CD4+ T lymphocytes. The percentage of cells undergoing apoptosis was
quantified by flow cytometry and measuring the proportion of cells with
sub-G1 DNA content and correlating it with HIV p24 production. Caspase
activities were measured at multiple time points after infection by
using specific fluorometric substrates (Fig. 1
). The pattern of caspase activation strongly suggested that the
intrinsic pathway of apoptosis induction was operational. This
suggestion was borne out by the following observations. The catalytic
activity of the apical caspase-2 and -9 increased after 2 days,
concomitantly with the activation of the executioner caspase-3.
Activated caspase-6 was detectable only 72 h after infection. No
activity of the death receptor-associated apical caspase-8 was observed
during the infection (up to 72 h). Caspase enzymatic activities
were corroborated by immunoblotting. Cleavage of the proform of
caspase-3 was observed in all samples, but in HIV-1 treated cells the
ratio of the cleaved and uncleaved pro-caspase product was increased as
early as 24 h and remained elevated up to 72 h relative to
the control. The levels of the pro-caspase-9 and -6 products were
reduced 48 and 72 h after infection, which suggests processing to
their active forms.
|
2. HIV induces p53 phosphorylation and activation
To study the role of p53 in the initiation of the apoptotic
pathway during HIV-1 infection, we measured the total level of p53 and
its phosphorylation at residue Ser15 by using a phospho-specific
antibody. Total and phosphorylated p53 levels increased 24 h after
HIV-1 infection. This HIV-triggered phosphorylation of p53 peaked at
48 h and remained detectable for up to 72 h (Fig. 2
). To confirm that phosphorylation and induction of p53 resulted in the
activation of the p53 pathway, we analyzed the protein and mRNA levels
of p53-induced genes, p21/CIP1/WAF1 (p21), HDM2, and Bax. Both Bax and
p21 levels increased 48 h after HIV-1 infection, and HDM2
increased after 72 h compared to uninfected
controls.
|
3. HIV up-regulates Fas ligand but only as a late event
To investigate whether HIV would activate an extrinsic apoptotic
pathway involving Fas ligand binding to Fas receptor, we analyzed the
expressions of signaling proteins involved in the Fas signaling
pathway. In primary cells, the protein levels of Fas receptor and of
Fas ligand were not modulated by HIV infection (data not shown), but
the expression of surface Fas ligand measured by flow cytometry was
increased significantly at 72 h. However, the Fas binding proteins
FADD, DAXX, and RIP were all down-regulated, which would be expected to
inhibit FasL-Fas-induced apoptosis.
CONCLUSIONS AND SIGNIFICANCE
We demonstrated that the intrinsic mitochondrial pathway of apoptosis is the primary mechanism that induces CD4+ T cells to undergo apoptosis. Mitochondrial membrane permeabilization may be a consequence of the activation of the p53 pathway. Once phosphorylated, p53 induces up-regulation of Bax, which may translocate to the mitochondrial membrane and promote cytochrome c and AIF release.
Furthermore, it appears that the Fas pathway does not play a primary role in HIV-induced apoptosis of CD4+ T lymphocytes. However, it is possible that Fas ligand might play a role in the depletion of noninfected bystander CD4 cells or CD8+ T cells by activating caspase-8.
This phenomenon may be especially relevant in primary acute infection when high levels of virus are present and no potent mechanisms of viral control are yet fully operational. The primary infection stage has the highest proportion of CD4 lymphocyte infected during the course of HIV infection. This p53-mediated apoptosis may be responsible for the precipitous drop in CD4+ T cells seen in primary acute HIV-infected patients, with eventual stabilization of both CD4 and viral loads. These events set the stage for determining the propensity for progression to AIDS. In summary, CD4 T+ cell death as a result of HIV-1 infection is mediated by the activation of p53 and the intrinsic mitochondrial apoptotic pathway. The mechanism by which HIV mediates this process remains to be further clarified.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0336fje To cite this article, use (November 9, 2000) FASEB J. 10.1096/fj.00-0336fje ![]()
2 The first two authors contributed equally to the study and the last two authors share senior authorship. ![]()
This article has been cited by other articles:
![]() |
D. Gutierrez-Sanmartin, E. Varela-Ledo, A. Aguilera, S. Romero-Yuste, P. Romero-Jung, A. Gomez-Tato, and B. J. Regueiro Implication of p38 mitogen-activated protein kinase isoforms ({alpha}, {beta}, {gamma} and {delta}) in CD4+ T-cell infection with human immunodeficiency virus type I J. Gen. Virol., July 1, 2008; 89(7): 1661 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ringrose, R. E. Jeeninga, B. Berkhout, and D. Speijer Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1 J. Virol., May 1, 2008; 82(9): 4320 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pauls, J. Senserrich, B. Clotet, and J. A. Este Inhibition of HIV-1 replication by RNA interference of p53 expression J. Leukoc. Biol., September 1, 2006; 80(3): 659 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schindler, J. Munch, and F. Kirchhoff Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism J. Virol., May 1, 2005; 79(9): 5489 - 5498. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Yue, C. M. Kovacs, R. C. Dimayuga, X. X. J. Gu, P. Parks, R. Kaul, and M. A. Ostrowski Preferential Apoptosis of HIV-1-Specific CD4+ T Cells J. Immunol., February 15, 2005; 174(4): 2196 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Perfettini, M. Castedo, R. Nardacci, F. Ciccosanti, P. Boya, T. Roumier, N. Larochette, M. Piacentini, and G. Kroemer Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope J. Exp. Med., January 18, 2005; 201(2): 279 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cunard, Y. Eto, J. T. Muljadi, C. K. Glass, C. J. Kelly, and M. Ricote Repression of IFN-{gamma} Expression by Peroxisome Proliferator-Activated Receptor {gamma} J. Immunol., June 15, 2004; 172(12): 7530 - 7536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nanua and F. K. Yoshimura Differential Cell Killing by Lymphomagenic Murine Leukemia Viruses Occurs Independently of p53 Activation and Mitochondrial Damage J. Virol., May 15, 2004; 78(10): 5088 - 5096. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Perfettini, T. Roumier, M. Castedo, N. Larochette, P. Boya, B. Raynal, V. Lazar, F. Ciccosanti, R. Nardacci, J. Penninger, et al. NF-{kappa}B and p53 Are the Dominant Apoptosis-inducing Transcription Factors Elicited by the HIV-1 Envelope J. Exp. Med., March 1, 2004; 199(5): 629 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. CASTEDO, J.-L. PERFETTINI, K. ANDREAU, T. ROUMIER, M. PIACENTINI, and G. KROEMER Mitochondrial Apoptosis Induced by the HIV-1 Envelope Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 19 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Chen and J. D. Chen Daxx Silencing Sensitizes Cells to Multiple Apoptotic Pathways Mol. Cell. Biol., October 15, 2003; 23(20): 7108 - 7121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Komoto, S. Tsuji, M. S. Ibrahim, Y.-G. Li, J. Warachit, K. Taniguchi, and K. Ikuta The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a Protective Role against Virus-Induced Apoptosis in Primary CD4+ T Lymphocytes J. Virol., October 1, 2003; 77(19): 10304 - 10313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Monroe, R. R. Berger, and M. M. Sanders Tissue-Protective Effects of Estrogen Involve Regulation of Caspase Gene Expression Mol. Endocrinol., June 1, 2002; 16(6): 1322 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. SZONDY, R. TOTH, E. SZEGEZDI, U. REICHERT, P. ANCIAN, and L. FESUS Cell Death in HIV Pathogenesis and Its Modulation by Retinoids Ann. N.Y. Acad. Sci., November 1, 2001; 946(1): 95 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castedo, K. F. Ferri, J. Blanco, T. Roumier, N. Larochette, J. Barretina, A. Amendola, R. Nardacci, D. Metivier, J. A. Este, et al. Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-induced Apoptosis Involves Mammalian Target of Rapamycin/FKBP12-Rapamycin-associated Protein-mediated p53 Phosphorylation J. Exp. Med., October 15, 2001; 194(8): 1097 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Petit, D. Arnoult, J.-D. Lelievre, L. M.-d. Parseval, A. J. Hance, P. Schneider, J. Corbeil, J. C. Ameisen, and J. Estaquier Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-independent Cell Death J. Biol. Chem., January 4, 2002; 277(2): 1477 - 1487. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |